A phase II, open-labeled, multi-center, randomized controlled trial of Vinblastine +/- Bevacizumab for the treatment of chemotherapy-naïve children with unresectable or progressive low grade glioma

  • Strong, Robyn (Project Manager)
  • Hansford, Jordan R. (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

LGG Avastin is an international Phase II, open-labelled, multi-centre, randomised controlled trial of vinblastine +/- bevacizumab (Avastin) for the treatment of chemotherapy-naïve children with unresectable or progressive low grade glioma (LGG). This trial will take place in Australia and will be sponsored by ANZCHOG. Participation in this trial will allow Australian patients’ access to an investigational agent, access to treatment protocols that are considered likely to result in better outcomes, and involvement in an international study that will inform the best practice for treating Australian children with unresectable or progressive LGG
Short titleLGG Avastin
StatusActive
Effective start/end date27/10/1730/06/23